1. A pharmaceutical complex capsule composition comprising 1) an independent unit of irbesartan comprising irbesartan or a pharmaceutically acceptable salt thereof； and 2) an independent HMG-CoA reductase inhibitor unit containing a HMG-CoA reductase inhibitor, or a pharmaceutically acceptable salt and alkaline additive thereof, wherein said independent units are separated from each other in a capsule. 2. The pharmaceutical complex capsule composition according to claim 1, wherein the HMG-CoA reductase inhibitor is selected from the group consisting of rosuvastatin, lovastatin, atorvastatin, pravastatin, fluvastatin, pitavastatin, simvastatin, rivastatin, cerivastatin, velostatin, omeva salt, meva precursor and mixtures thereof. 3. The pharmaceutical complex capsule composition according to claim 2, wherein the HMG-CoA reductase inhibitor is atorvastatin calcium. The pharmaceutical complex capsule composition according to claim 1, wherein an independent unit of irbesartan and an independent unit of an inhibitor of HMG-CoA reductase are present, each in the form of a granule or tablet. The pharmaceutical complex capsule composition according to claim 4, wherein at least one of the independent unit of irbesartan and the independent unit of the inhibitor of HMG-CoA reductase is presented in tablet form. The pharmaceutical complex capsule composition according to claim 4, wherein the tablet has a diameter of 3 mm or less. The pharmaceutical complex capsule composition according to claim 4, wherein the tablet has a thickness of 3 mm or less. The pharmaceutical complex capsule composition of claim 4, wherein the tablet further comprises a coating layer. The pharmaceutical complex capsule composition according to claim 8,1. Фармацевтическая сложная капсульная композиция, включающая1) независимую единицу ирбесартана, включающую ирбесартан или его фармацевтически приемлемую соль； и2) независимую единицу ингибитора ГМГ-КоА редуктазы, содержащую ингибитор ГМГ-КоА редуктазы, ил
